Literature DB >> 30317589

Chronic kidney disease after 5/6 nephrectomy disturbs the intestinal microbiota and alters intestinal motility.

Kazuhiro Nishiyama1, Kimiya Aono1, Yasuyuki Fujimoto1, Mitsuru Kuwamura2, Toshiya Okada3, Hayato Tokumoto4, Takeshi Izawa2, Ryoichi Okano5, Hidemitsu Nakajima1, Tadayoshi Takeuchi1, Yasu-Taka Azuma1.   

Abstract

Organ-organ crosstalk is involved in homeostasis. Gastrointestinal symptoms are common in patients with renal failure. The aim of this study was to elucidate the relationship between gastrointestinal motility and gastrointestinal symptoms in chronic kidney disease. We performed studies in C57BL/6 mice with chronic kidney disease after 5/6 nephrectomy. Gastrointestinal motility was evaluated by assessing the ex vivo responses of ileum and distal colon strips to electrical field stimulation. Feces were collected from mice, and the composition of the gut microbiota was analyzed using 16S ribosomal RNA sequencing. Mice with chronic kidney disease after 5/6 nephrectomy showed a decreased amount of stool, and this constipation was correlated with a suppressed contraction response in ileum motility and decreased relaxation response in distal colon motility. Spermine, one of the uremic toxins, inhibited the contraction response in ileum motility, but four types of uremic toxins showed no effect on the relaxation response in distal colon motility. The 5/6 nephrectomy procedure disturbed the balance of the gut microbiota in the mice. The motility dysregulation and constipation were resolved by antibiotic treatments. The expression levels of interleukin 6, tumor necrosis factor-α, and iNOS in 5/6 nephrectomy mice were increased in the distal colon but not in the ileum. In addition, macrophage infiltration in 5/6 nephrectomy mice was increased in the distal colon but not in the ileum. We found that 5/6 nephrectomy altered gastrointestinal motility and caused constipation by changing the gut microbiota and causing colonic inflammation. These findings indicate that renal failure was remarkably associated with gastrointestinal dysregulation.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  chronic kidney disease (CKD); gastrointestinal motility; gut microbiota

Mesh:

Year:  2018        PMID: 30317589     DOI: 10.1002/jcp.27408

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  13 in total

Review 1.  The gut microbiota and its relationship with chronic kidney disease.

Authors:  Consuelo Plata; Cristino Cruz; Luz G Cervantes; Victoria Ramírez
Journal:  Int Urol Nephrol       Date:  2019-10-01       Impact factor: 2.370

2.  A Renal Clinician's Guide to the Gut Microbiota.

Authors:  Matthew Snelson; Annabel Biruete; Catherine McFarlane; Katrina Campbell
Journal:  J Ren Nutr       Date:  2020-01-09       Impact factor: 3.655

3.  Yishen Qingli Heluo Granule Ameliorates Renal Dysfunction in 5/6 Nephrectomized Rats by Targeting Gut Microbiota and Intestinal Barrier Integrity.

Authors:  Xian Sun; Jie Chen; Yiting Huang; Sha Zhu; Shuaishuai Wang; Zijing Xu; Junfeng Zhang; Wei Sun
Journal:  Front Pharmacol       Date:  2022-06-22       Impact factor: 5.988

4.  Feeling gutted in chronic kidney disease (CKD): Gastrointestinal disorders and therapies to improve gastrointestinal health in individuals CKD, including those undergoing dialysis.

Authors:  Annabel Biruete; Andrea Shin; Brandon M Kistler; Sharon M Moe
Journal:  Semin Dial       Date:  2021-10-27       Impact factor: 2.886

Review 5.  Plant-Based Diets, the Gut Microbiota, and Trimethylamine N-Oxide Production in Chronic Kidney Disease: Therapeutic Potential and Methodological Considerations.

Authors:  Gretchen N Wiese; Annabel Biruete; Ranjani N Moorthi; Sharon M Moe; Stephen R Lindemann; Kathleen M Hill Gallant
Journal:  J Ren Nutr       Date:  2020-06-29       Impact factor: 3.655

6.  Preliminary evaluation of fecal fatty acid concentrations in cats with chronic kidney disease and correlation with indoxyl sulfate and p-cresol sulfate.

Authors:  Stacie Summers; Jessica M Quimby; Robert Kyle Phillips; Jonathan Stockman; Anitha Isaiah; Jonathan A Lidbury; Joerg M Steiner; Jan Suchodolski
Journal:  J Vet Intern Med       Date:  2019-11-06       Impact factor: 3.333

7.  Using circulating O-sulfotyrosine in the differential diagnosis of acute kidney injury and chronic kidney disease.

Authors:  Shuai Chen; Yong-Hua Liu; Dao-Peng Dai; Zheng-Bin Zhu; Yang Dai; Zhi-Ming Wu; Li-Ping Zhang; Zhi-Feng Duan; Lin Lu; Feng-Hua Ding; Jin-Zhou Zhu; Rui-Yan Zhang
Journal:  BMC Nephrol       Date:  2021-02-23       Impact factor: 2.388

Review 8.  Chronic Kidney Disease, Gut Dysbiosis, and Constipation: A Burdensome Triplet.

Authors:  Ryota Ikee; Naomi Sasaki; Takuji Yasuda; Sawako Fukazawa
Journal:  Microorganisms       Date:  2020-11-25

9.  Alisol B 23-acetate attenuates CKD progression by regulating the renin-angiotensin system and gut-kidney axis.

Authors:  Hua Chen; Min-Chang Wang; Yuan-Yuan Chen; Lin Chen; Yan-Ni Wang; Nosratola D Vaziri; Hua Miao; Ying-Yong Zhao
Journal:  Ther Adv Chronic Dis       Date:  2020-05-20       Impact factor: 5.091

Review 10.  Biological characteristics of IL-6 and related intestinal diseases.

Authors:  Yuexin Guo; Boya Wang; Tiantian Wang; Lei Gao; Ze-Jun Yang; Fei-Fei Wang; Hong-Wei Shang; Rongxuan Hua; Jing-Dong Xu
Journal:  Int J Biol Sci       Date:  2021-01-01       Impact factor: 6.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.